D

Taysha Gene Therapies, Inc. TSHA

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.97$4.18
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 7.90% 25.51%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -17.55% 16.78%
Operating Income 17.55% -16.78%
Income Before Tax 16.10% -9.97%
Income Tax Expenses -- --
Earnings from Continuing Operations 16.10% -9.97%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 16.10% -9.97%
EBIT 17.55% -16.78%
EBITDA 17.58% -16.90%
EPS Basic 23.81% -9.25%
Normalized Basic EPS 28.83% -17.77%
EPS Diluted 23.81% -9.25%
Normalized Diluted EPS 28.83% -17.77%
Average Basic Shares Outstanding 10.04% 0.66%
Average Diluted Shares Outstanding 10.04% 0.66%
Dividend Per Share -- --
Payout Ratio -- --